Illumina CEO: Array Market Returned to 'Normalcy' in 2010 as BeadChip Sales Rose 10 Percent

CEO Jay Flatley told investors at the JP Morgan Healthcare Conference in San Francisco last week that "2009 was a challenging year for us in the array business," but that 2010 was a "year when the market returned to some degree of normalcy."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.